Fast clearance of lipid droplets through MAP1S-activated autophagy suppresses clear cell renal cell carcinomas and promotes patient survival

Oncotarget

Volumn 7, Issue 5, 2016, Pages 6255-6265

  Xu, Guibin ^a,b   Jiang, Yaodong ^c   Xiao, Yuansong ^d   Liu, Xian De ^e   Yue, Fei ^b   Li, Wenjiao ^b   Li, Xun ^a   He, Yongzhong ^a   Jiang, Xianhan ^a   Huang, Hai ^b   Chen, Qi ^b   Jonasch, Eric ^e   Liu, Leyuan ^b,f  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

ADFP; ccRCC; Lipophagy; MAP1S; Prognosis

Indexed keywords

FAT DROPLET; MAP1S PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; MAP1S PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DISTANT METASTASIS; DOUBLE STRANDED DNA BREAK; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; RENAL CELL CARCINOMA CELL LINE; SURVIVAL RATE; SURVIVAL TIME; ANIMAL; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SURVIVAL ANALYSIS;

ANIMALS; AUTOPHAGY; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIPID DROPLETS; MALE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 84958078659     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6669     Document Type: Article

References (47)

1. Mizushima N, Levine B, Cuervo AM and Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008; 451:1069-1075.
2. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM and Czaja MJ. Autophagy regulates lipid metabolism. Nature. 2009; 458:1131-1135.
3. Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD, Klionsky DJ, Ohsumi M and Ohsumi Y. A protein conjugation system essential for autophagy. Nature. 1998; 395:395-398.
4. Liu L, McKeehan WL, Wang F and Xie R. MAP1S enhances autophagy to suppress tumorigenesis. Autophagy. 2012; 8:278-280.
5. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA and Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008; 9:847-856.
6. Liu L, Trimarchi JR, Smith PJ and Keefe DL. Mitochondrial dysfunction leads to telomere attrition and genomic instability. Aging Cell. 2002; 1:40-46.
7. Mishra PK, Raghuram GV, Panwar H, Jain D, Pandey H and Maudar KK. Mitochondrial oxidative stress elicits chromosomal instability after exposure to isocyanates in human kidney epithelial cells. Free Radic Res. 2009; 43:718-728.
8. D'Angiolella V, Santarpia C and Grieco D. Oxidative stress overrides the spindle checkpoint. Cell Cycle. 2007; 6:576-579.
9. Li M, Fang X, Baker DJ, Guo L, Gao X, Wei Z, Han S, van Deursen JM and Zhang P. The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc Nat Acad Sci USA. 2010; 107:14188-14193.
10. McClintock B. The Fusion of Broken Ends of Chromosomes Following Nuclear Fusion. Proc Nat Acad Sci USA. 1942; 28:458-463.
11. Lamkanfi M and Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014; 157:1013-1022.
12. Ryter SW, Mizumura K and Choi AM. The Impact of Autophagy on Cell Death Modalities. Internat J Cell Biol. 2014; 2014:502676.
13. Yu J, Nagasu H, Murakami T, Hoang H, Broderick L, Hoffman HM and Horng T. Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy. Proc Nat Acad Sci USA. 2014; 111:15514-15519.
14. Terlizzi M, Casolaro V, Pinto A and Sorrentino R. Inflammasome: cancer's friend or foe? Pharma Therapeut. 2014; 143:24-33.
15. Mann SS and Hammarback JA. Molecular characterization of light chain 3. A microtubule binding subunit of MAP1A and MAP1B. J Biol Chem. 1994; 269:11492-11497.
16. Mann SS and Hammarback JA. Gene localization and developmental expression of light chain 3: a common subunit of microtubule-associated protein 1A(MAP1A) and MAP1B. J Neurosci Res. 1996; 43:535-544.
17. Schoenfeld TA, McKerracher L, Obar R and Vallee RB. MAP 1A and MAP 1B are structurally related microtubule associated proteins with distinct developmental patterns in the CNS. J Neurosci. 1989; 9:1712-1730.
18. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000; 19:5720-5728.
19. Xie R, Nguyen S, McKeehan K, Wang F, McKeehan WL and Liu L. Microtubule-associated protein 1S (MAP1S) bridges autophagic components with microtubules and mitochondria to affect autophagosomal biogenesis and degradation. J Biol Chem. 2011; 286:10367-10377.
20. Li W, Zou J, Yue F, Song K, Chen Q, McKeehan WL, Wang F, Xu G, Huang H, Yi J and Liu L. Defects in MAP1S-mediated autophagy cause reduction of mouse lifespans especially when fibronectin is overexpressed. Aging Cell. 2015; Doi:1 10.1111/acel.12441.
21. Vandin F, Clay P, Upfal E and Raphael BJ. Discovery of Mutated Subnetworks Associated with Clinical Data in Cancer. Pac Symp Biocomput. 2012; 2012:55-66.
22. Xie R, Wang F, McKeehan WL and Liu L. Autophagy enhanced by microtubule-and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis. Can Res. 2011; 71:7537-7546.
23. Jiang X, Zhong W, Huang H, He H, Jiang F, Chen Y, Yue F, Zou J, Li X, He Y, You P, Yang W, Lai Y, Wang F and Liu L. Autophagy Defects Suggested by Low Levels of Autophagy Activator MAP1S and High Levels of Autophagy Inhibitor LRPPRC Predict Poor Prognosis of Prostate Cancer Patients. Mol Carcinog. 2015; 54:1194-204.
24. Frew IJ and Moch H. A clearer view of the molecular complexity of clear cell renal cell carcinoma. Annu Rev Pathol. 2015; 10:263-289.
25. Liu K and Czaja MJ. Regulation of lipid stores and metabolism by lipophagy. Cell Death Different. 2013; 20:3-11.
26. Kondo Y, Kanzawa T, Sawaya R and Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Can. 2005; 5:726-734.
27. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, Al-Younes HM, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012; 8:445-544.
28. Cryns V and Yuan J. Proteases to die for. Gene Develop. 1998; 12:1551-1570.
29. Desagher S and Martinou JC. Mitochondria as the central control point of apoptosis. Trend Cell Biol. 2000; 10:369-377.
30. Suen YK, Fung KP, Choy YM, Lee CY, Chan CW and Kong SK. Concanavalin A induced apoptosis in murine macrophage PU5-1.8 cells through clustering of mitochondria and release of cytochrome c. Apoptosis. 2000; 5:369-377.
31. Thomas WD, Zhang XD, Franco AV, Nguyen T and Hersey P. TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria. J Immunol. 2000; 165:5612-5620.
32. De Vos K, Goossens V, Boone E, Vercammen D, Vancompernolle K, Vandenabeele P, Haegeman G, Fiers W and Grooten J. The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membraneproximal region. J Biol Chem. 1998; 273:9673-9680.
33. Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Metivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P and Kroemer G. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005; 25:1025-1040.
34. Shibata M, Yoshimura K, Tamura H, Ueno T, Nishimura T, Inoue T, Sasaki M, Koike M, Arai H, Kominami E and Uchiyama Y. LC3, a microtubule-associated protein1A/B light chain3, is involved in cytoplasmic lipid droplet formation. Biochem Biophys Res Commun. 2010; 393:274-279.
35. Shibata M, Yoshimura K, Furuya N, Koike M, Ueno T, Komatsu M, Arai H, Tanaka K, Kominami E and Uchiyama Y. The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem Biophys Res Commun. 2009; 382:419-423.
36. Baerga R, Zhang Y, Chen PH, Goldman S and Jin S. Targeted deletion of autophagy-related 5 (atg5) impairs adipogenesis in a cellular model and in mice. Autophagy. 2009; 5:1118-1130.
37. Kiss E, Kranzlin B, Wagenblabeta K, Bonrouhi M, Thiery J, Grone E, Nordstrom V, Teupser D, Gretz N, Malle E and Grone HJ. Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by liver X receptors. Amer J Pathol. 2013; 182:727-741.
38. Kundu JK and Surh YJ. Emerging avenues linking inflammation and cancer. Free Rad Biol Med. 2012; 52:2013-2037.
39. Moss SF and Blaser MJ. Mechanisms of disease: Inflammation and the origins of cancer. Nat Clin Pract Oncol. 2005; 2:90-97; quiz 91 p following 113.
40. Chiang AC and Massague J. Molecular basis of metastasis. New England J Med. 2008; 359:2814-2823.
41. Kitamura T, Qian BZ and Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015; 15:73-86.
42. Zou J, Yue F, Jiang X, Li W, Yi J and Liu L. Mitochondrionassociated protein LRPPRC suppresses the initiation of basal levels of autophagy via enhancing Bcl-2 stability. Biochem J. 2013; 454:447-457.
43. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM and Czaja MJ. Autophagy regulates lipid metabolism. Nature. 2009; 458:1131-1135.
44. Greene FL and Sobin LH. A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC. J Surg Oncol. 2009; 99:269-272.
45. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B and Iczkowski K. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997; 80:987-989.
46. Ding Y, Chen B, Wang S, Zhao L, Chen J, Ding Y, Chen L and Luo R. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients. Internat J Cancer. 2009; 124:653-658.
47. Jiang X, Li X, Huang H, Jiang F, Lin Z, He H, Chen Y, Yue F, Zou J, He Y, You P, Wang W, Yang W, Zhao H, Lai Y, Wang F, et al. Elevated levels of mitochondrion-associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer. Cancer. 2014; 120:1228-1236.